Machine learning & AI

Novo Nordisk signs deal with OpenAI to develop new drugs

Danish pharmaceuticals group Novo Nordisk, maker of the popular Ozempic and Wegovy anti-obesity drugs, announced Tuesday a "strategic partnership" with OpenAI to accelerate the development of new medications.

Consumer & Gadgets

Reactions to data breaches fade faster than expected

Data breaches, such as the recent incidents at Odido and Basic-Fit, trigger feelings of anxiety and loss of trust among both victims and those who may have been affected. New international research shows that although data ...

Engineering

Bridges, roadways threatened by changes in weather patterns

The combination of extreme weather conditions, like atmospheric rivers, and aging infrastructure is putting increasing pressures on Canadian highways, bridges and tunnels—many of which are almost 100 years old. UBC Okanagan ...

page 33 from 40